Targeting the alpha subunit of IL-3 receptor (CD123) in patients with acute leukemia-Reference-Cited by-同舟云学术

Targeting the alpha subunit of IL-3 receptor (CD123) in patients with acute leukemia

Published:2020-07-21 Issue:10 Volume:16 Page:2341-2348
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Aldoss Ibrahim¹,Clark Mary²,Song Joo Y³^ORCID,Pullarkat Vinod¹

Affiliation:

1. Gehr Family Center for Leukemia Research, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Medical Center, Duarte, CA, USA

2. Department of Clinical and Translational Project Development, City of Hope National Medical Center, Duarte, CA, USA

3. Department of Pathology, City of Hope National Medical Center, Duarte, CA, USA

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2020.1788299

Reference52 articles.

1. Structure of the murine Jak2 protein-tyrosine kinase and its role in interleukin 3 signal transduction.

2. The Structural and Functional Basis of Cytokine Receptor Activation: Lessons From the Common β Subunit of the Granulocyte-Macrophage Colony-Stimulating Factor, Interleukin-3 (IL-3), and IL-5 Receptors

3. CD123 expression patterns and selective targeting with a CD123-targeted antibody-drug conjugate (IMGN632) in acute lymphoblastic leukemia

4. Overexpression of CD123 correlates with the hyperdiploid genotype in acute lymphoblastic leukemia

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IL-3: key orchestrator of inflammation;Frontiers in Immunology;2024-06-13

2. Impact of scFv on Functionality and Safety of Third-Generation CD123 CAR T Cells;Cancer Immunology Research;2024-05-30

3. Asymmetric anti-CLL-1×CD3 bispecific antibody, ABL602 2+1, with attenuated CD3 affinity endows potent antitumor activity but limited cytokine release;Journal for ImmunoTherapy of Cancer;2023-10

4. North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need;Blood;2023-02-09

5. Novel Therapeutics Targeting Cancer Stem Cell Surface Markers;Cancer Stem Cells: Basic Concept and Therapeutic Implications;2023